ztlido Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Ztlido, and what generic alternatives are available?

Ztlido is a drug marketed by Scilex Pharms and is included in one NDA. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has thirty-seven patent family members in eighteen countries.

The generic ingredient in ZTLIDO is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the lidocaine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ztlido

A generic version of ztlido was approved as lidocaine by ACTAVIS LABS UT INC on August 23^rd, 2012.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ztlido?
What are the global sales for ztlido?
What is Average Wholesale Price for ztlido?

Summary for ztlido

International Patents:	37
US Patents:	8
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	132
Clinical Trials:	8
Patent Applications:	5,208
Drug Prices:	Drug price information for ztlido
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ztlido
What excipients (inactive ingredients) are in ztlido?	ztlido excipients list
DailyMed Link:	ztlido at DailyMed

Drug patent expirations by year for ztlido

Recent Clinical Trials for ztlido

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Scilex Pharmaceuticals, Inc.	Phase 1

See all ztlido clinical trials

Pharmacology for ztlido

Drug Class	Amide Local Anesthetic Antiarrhythmic
Physiological Effect	Local Anesthesia

Paragraph IV (Patent) Challenges for ZTLIDO

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ZTLIDO	Topical Patch	lidocaine	1.80%	207962	1	2022-03-17

US Patents and Regulatory Information for ztlido

ztlido is protected by eight US patents.

Patents protecting ztlido

Non-aqueous patch
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR RELIEVING THE PAIN ASSOCIATED WITH POST-HERPETIC NEURALGIA

Non-aqueous patch
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Non-aqueous patch
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR RELIEVING THE PAIN ASSOCIATED WITH POST-HERPETIC NEURALGIA

Non-aqueous patch
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Scilex Pharms	ZTLIDO	lidocaine	PATCH;TOPICAL	207962-001	Feb 28, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Scilex Pharms	ZTLIDO	lidocaine	PATCH;TOPICAL	207962-001	Feb 28, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Scilex Pharms	ZTLIDO	lidocaine	PATCH;TOPICAL	207962-001	Feb 28, 2018		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ztlido

See the table below for patents covering ztlido around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Serbia	57451	NE-VODENA OBLOGA (NON-AQUEOUS PATCH)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2013046335		⤷ Sign Up
Mexico	2013013121	PARCHE NO ACUOSO. (NON-AQUEOUS PATCH.)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ztlido

Recent Clinical Trials for ztlido

Pharmacology for ztlido

Paragraph IV (Patent) Challenges for ZTLIDO

Patents protecting ztlido

Make Better Decisions: Try a trial or see plans & pricing